{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:30Z","timestamp":1789685010360,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.029","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T14:08:56Z","timestamp":1258553336000},"page":"7141-7148","source":"Crossref","is-referenced-by-count":74,"title":["Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals"],"prefix":"10.1016","volume":"27","author":[{"given":"Charles E.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Franka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry D.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin I.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Cieslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.029_bib1","series-title":"Fields virology","first-page":"1363","article-title":"Rhabdoviridae","author":"Lyles","year":"2007"},{"key":"10.1016\/j.vaccine.2009.09.029_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00124784-199809000-00009","article-title":"Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States","volume":"4","author":"Krebs","year":"1998","journal-title":"J Public Health Manag Pract"},{"key":"10.1016\/j.vaccine.2009.09.029_bib3","unstructured":"World Health Organization. WHO expert committee on rabies. 8th report. WHO technical report series, no. 824. Geneva, Switzerland; 1992."},{"key":"10.1016\/j.vaccine.2009.09.029_bib4","unstructured":"World Health Organization. WHO expert consultation on rabies. 1st report. WHO technical report series, no. 931. Geneva, Switzerland; 2005."},{"issue":"RR-3","key":"10.1016\/j.vaccine.2009.09.029_bib5","first-page":"1","article-title":"Human rabies prevention\u2014United States 2008. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2009.09.029_bib6","unstructured":"World Health Organization. WHO expert committee on rabies. 6th report. WHO technical report series, no. 523. Geneva, Switzerland; 1973."},{"key":"10.1016\/j.vaccine.2009.09.029_bib7","unstructured":"World Health Organization. WHO expert committee on rabies. 7th report. WHO technical report series, no. 709. Geneva, Switzerland; 1984."},{"issue":"RR-1","key":"10.1016\/j.vaccine.2009.09.029_bib8","first-page":"1","article-title":"Human rabies prevention\u2014United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","year":"1999","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2009.09.029_bib9","first-page":"95","article-title":"The pathogenesis of rabies and other lyssaviral infections: recent studies","volume":"187","author":"Charlton","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.09.029_bib10","first-page":"493","article-title":"Use of rabies virus as a transneuronal tracer of neuronal connections: implications for the understanding of rabies pathogenesis","volume":"131","author":"Ugolini","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2009.09.029_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13550280590900418","article-title":"The role of immune responses in the pathogenesis of rabies","volume":"11","author":"Hooper","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2009.09.029_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/290590a0","article-title":"Acute rabies death mediated by antibody","volume":"290","author":"Prabhakar","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.09.029_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/344905","article-title":"Management of rabies in humans","volume":"36","author":"Jackson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib14","first-page":"367","article-title":"Generalised cranial artery spasm in human rabies","volume":"131","author":"Willoughby","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2009.09.029_bib15","first-page":"45","article-title":"Pathogenesis of rabies","volume":"292","author":"Dietzschold","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2009.09.029_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/vbz.2007.0209","article-title":"Investigation of the role of healthy dogs as potential carriers of rabies virus","volume":"8","author":"Zhang","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/0003-4819-128-11-199806010-00012","article-title":"Epidemiology of human rabies in the United States, 1980 to 1996","volume":"128","author":"Noah","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2009.09.029_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 post-exposure schedule","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0264-410X(88)90225-3","article-title":"Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment","volume":"6","author":"Vodopija","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(91)90244-Z","article-title":"One-year study of the 2-1-1 intramuscular post-exposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine","volume":"9","author":"Chutivongse","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0264-410X(97)00207-7","article-title":"Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine","volume":"15","author":"Vodopija","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib22","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0264-410X(98)00427-7","article-title":"Rabipur: a reliable vaccine for rabies protection","volume":"17","author":"Vodopija","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib23","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia","volume":"76","author":"Lang","year":"1998","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2009.09.029_bib24","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.1976.03270250019017","article-title":"Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum","volume":"236","author":"Bahmanyar","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.09.029_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-1157(78)80007-9","article-title":"Immunization against rabies with rabies immune globulin, human (RIGH) and a human diploid cell strain (HDCS) rabies vaccine","volume":"6","author":"Kuwert","year":"1978","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2009.09.029_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0092-1157(89)90032-2","article-title":"Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects","volume":"17","author":"Aoki","year":"1989","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2009.09.029_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1045-1056(05)80048-X","article-title":"Rabies neutralizing antibody in serum of children compared to adults following post-exposure prophylaxis","volume":"20","author":"Aoki","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2009.09.029_bib28","first-page":"461","article-title":"The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment","volume":"24","author":"Wasi","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2009.09.029_bib29","first-page":"23","article-title":"Five-year longitudinal study of efficacy and safety of purified Vero cell rabies vaccine for post-exposure prophylaxis of rabies in Indian population","volume":"29","author":"Seghal","year":"1997","journal-title":"J Commun Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/biol.1997.0117","article-title":"Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies","volume":"26","author":"Lang","year":"1998","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2009.09.029_bib31","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/S0264-410X(01)00238-9","article-title":"Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine","volume":"19","author":"Jones","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib32","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.09.029_bib33","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4161\/hv.1.5.2110","article-title":"Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis","volume":"1","author":"Sudarshan","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2009.09.029_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(92)90029-J","article-title":"Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine","volume":"0","author":"Briggs","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/clin.1994.1088","article-title":"Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man","volume":"71","author":"Thraenhart","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2009.09.029_bib37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/515267","article-title":"Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy","volume":"177","author":"Strady","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1708-8305.2006.00097.x","article-title":"Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine","volume":"14","author":"Malerczyk","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2009.09.029_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1708-8305.1999.tb00844.x","article-title":"Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously","volume":"6","author":"Naraporn","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2009.09.029_bib40","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"Suwansrinon","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trstmh.2007.11.010","article-title":"Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children","volume":"102","author":"Vien","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2009.09.029_bib42","doi-asserted-by":"crossref","first-page":"S739","DOI":"10.1093\/clinids\/10.Supplement_4.S739","article-title":"Animal models in the pathogenesis and treatment of rabies","volume":"10","author":"Baer","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib43","first-page":"1","article-title":"Effective protection of monkeys against death from street virus by postexposure administration of tissue-culture rabies vaccine","volume":"45","author":"Sikes","year":"1971","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2009.09.029_bib44","first-page":"807","article-title":"An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine","volume":"57","author":"Baer","year":"1979","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2009.09.029_bib45","first-page":"289","article-title":"Evaluation of postexposure vaccination against rabies in cattle","volume":"20","author":"Basheer","year":"1997","journal-title":"New Microbiol"},{"key":"10.1016\/j.vaccine.2009.09.029_bib46","first-page":"691","article-title":"Efficacy of the administration of serum and vaccine for the antirabies treatment of experimentally-infected sheep","volume":"14","author":"Baltazar","year":"1995","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2009.09.029_bib47","first-page":"434","article-title":"Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyper immune globulin (human)","volume":"53","author":"Cho","year":"1989","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2009.09.029_bib48","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2460\/ajvr.2002.63.1096","article-title":"Postexposure prophylaxis for prevention of rabies in dogs","volume":"63","author":"Hanlon","year":"2002","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2009.09.029_bib49","series-title":"Proceedings of the Symposium on Rabies Control in Asia","first-page":"213","article-title":"Utility of monoclonal antibodies in the post-exposure treatment of rabies","author":"Rupprecht","year":"1993"},{"key":"10.1016\/j.vaccine.2009.09.029_bib50","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(00)00516-8","article-title":"The incurable wound revisited: progress in human rabies prevention?","volume":"19","author":"Hanlon","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.09.034","article-title":"Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccine","author":"Franka","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/22.2.228","article-title":"Failure of postexposure treatment of rabies in children","volume":"22","author":"Wilde","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib53","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/427700","article-title":"Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India","volume":"40","author":"Matha","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib54","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1016\/j.vaccine.2007.08.054","article-title":"Failures of post-exposure rabies prophylaxis","volume":"25","author":"Wilde","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib55","series-title":"The natural history of rabies","first-page":"620","year":"1991"},{"key":"10.1016\/j.vaccine.2009.09.029_bib56","unstructured":"Association for the Prevention and Control of Rabies (APCRI) in India. Assessing the burden of rabies in India: WHO sponsored national multi-centric rabies survey 2003. Final report May 2004. 104 pp. Available at: http:\/\/www.apcri.org\/. Accessed on: August 25, 2009."},{"key":"10.1016\/j.vaccine.2009.09.029_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey","volume":"11","author":"Sudarshan","year":"2007","journal-title":"Intl J Infect Dis"},{"issue":"November","key":"10.1016\/j.vaccine.2009.09.029_bib58","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1371\/journal.pntd.0000339","article-title":"Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies","volume":"2","author":"Hampson","year":"2008","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib59","unstructured":"Blanton JD. Analysis of exposure characteristics and treatment completion among persons receiving rabies post-exposure prophylaxis. Masters thesis. Emory University; 2003. 69 pp."},{"key":"10.1016\/j.vaccine.2009.09.029_bib60","series-title":"Vaccines","first-page":"687","article-title":"Rabies vaccine","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.029_bib61","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1016\/j.vaccine.2008.05.048","article-title":"Cost effectiveness of rabies post exposure prophylaxis","volume":"26","author":"Dhankhar","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.029_bib62","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3201\/eid1112.041278","article-title":"Rabies postexposure prophylaxis, New York, 1995\u20132000","volume":"11","author":"Blanton","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib63","unstructured":"U.S. Census Bureau. Census clock. Available at: http:\/\/www.census.gov\/. Accessed on: May 14, 2009."},{"key":"10.1016\/j.vaccine.2009.09.029_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7589\/0090-3558-43.2.251","article-title":"Estimating the direct and indirect costs of rabies exposure: a retrospective study in southern California (1998\u20132003)","volume":"43","author":"Shwiff","year":"2007","journal-title":"J Wildlife Dis"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2009.09.029_bib65","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence","volume":"42","author":"CDC","year":"1993","journal-title":"MMWR Recomm Rep"},{"issue":"RR-15","key":"10.1016\/j.vaccine.2009.09.029_bib66","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.029_bib67","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1086\/324087","article-title":"Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts","volume":"33","author":"Tantawichien","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.029_bib68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/003655401750174183","article-title":"Failure of pre- and postexposure rabies vaccinations in a child infected with HIV","volume":"33","author":"Pancharoen","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib69","first-page":"61","article-title":"Clinical trials in healthy volunteers with the new purified chick embryo cell rabies vaccine for man","volume":"16","author":"Bijok","year":"1984","journal-title":"J Commun Dis"},{"key":"10.1016\/j.vaccine.2009.09.029_bib70","first-page":"157","article-title":"Intradermal simulated rabies postexposure prophylaxis using purified chick embryo rabies vaccine","volume":"77","author":"Charanasri","year":"1994","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.vaccine.2009.09.029_bib71","unstructured":"Advisory Committee on Immunization Practices. ACIP provisional recommendations for the prevention of rabies. Available at: http:\/\/www.cdc.gov\/vaccines\/recs\/provisional\/default.htm#acip; Accessed on: August 25, 2009."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901353X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901353X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T05:23:35Z","timestamp":1544851415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0901353X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":71,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X0901353X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}